BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21642358)

  • 1. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
    Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
    Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.
    Schonfeld SJ; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson AA; Xu L; Wheeler W; Guénel P; Rajaraman P; de Vathaire F; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ; Brenner AV
    Thyroid; 2012 Feb; 22(2):151-6. PubMed ID: 22224819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.
    Aschebrook-Kilfoy B; Neta G; Brenner AV; Hutchinson A; Pfeiffer RM; Sturgis EM; Xu L; Wheeler W; Doody MM; Chanock SJ; Sigurdson AJ
    Endocr Relat Cancer; 2012 Jun; 19(3):333-44. PubMed ID: 22389382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.
    Neta G; Yu CL; Brenner A; Gu F; Hutchinson A; Pfeiffer R; Sturgis EM; Xu L; Linet MS; Alexander BH; Chanock S; Sigurdson AJ
    Laryngoscope; 2012 May; 122(5):1040-2. PubMed ID: 22275265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
    Lonjou C; Damiola F; Moissonnier M; Durand G; Malakhova I; Masyakin V; Le Calvez-Kelm F; Cardis E; Byrnes G; Kesminiene A; Lesueur F
    BMC Cancer; 2017 May; 17(1):328. PubMed ID: 28499365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the ATM gene polymorphisms with papillary thyroid cancer.
    Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
    Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
    Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
    Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
    Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.